India · Delayed Price · Currency is INR Laurus Labs Statistics
Total Valuation
Laurus Labs has a market cap or net worth of INR 1.32 trillion. The enterprise value is 1.34 trillion.
| Market Cap | 1.32T |
| Enterprise Value | 1.34T |
Important Dates
The last earnings date was Thursday, October 29, 2026.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | Nov 6, 2026 |
Share Statistics
Laurus Labs has 540.31 million shares outstanding. The number of shares has increased by 0.17% in one year.
| Current Share Class | 540.31M |
| Shares Outstanding | 540.31M |
| Shares Change (YoY) | +0.17% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 27.89% |
| Owned by Institutions (%) | 28.78% |
| Float | 365.91M |
Valuation Ratios
The trailing PE ratio is 98.32 and the forward PE ratio is 72.12. Laurus Labs's PEG ratio is 1.87.
| PE Ratio | 98.32 |
| Forward PE | 72.12 |
| PS Ratio | 16.16 |
| PB Ratio | 20.45 |
| P/TBV Ratio | 21.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 94.68 |
| PEG Ratio | 1.87 |
Enterprise Valuation
| EV / Earnings | 96.39 |
| EV / Sales | 16.51 |
| EV / EBITDA | 54.24 |
| EV / EBIT | 68.44 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.31, with a Debt / Equity ratio of 0.42.
| Current Ratio | 1.31 |
| Quick Ratio | 0.58 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | 1.10 |
| Debt / FCF | n/a |
| Interest Coverage | 12.12 |
Financial Efficiency
Return on equity (ROE) is 23.97% and return on invested capital (ROIC) is 17.21%.
| Return on Equity (ROE) | 23.97% |
| Return on Assets (ROA) | 11.28% |
| Return on Invested Capital (ROIC) | 17.21% |
| Return on Capital Employed (ROCE) | 24.98% |
| Weighted Average Cost of Capital (WACC) | 5.45% |
| Revenue Per Employee | 11.08M |
| Profits Per Employee | 1.90M |
| Employee Count | 7,059 |
| Asset Turnover | 0.75 |
| Inventory Turnover | 1.33 |
Taxes
In the past 12 months, Laurus Labs has paid 4.27 billion in taxes.
| Income Tax | 4.27B |
| Effective Tax Rate | 24.29% |
Stock Price Statistics
The stock price has increased by +149.25% in the last 52 weeks. The beta is 0.22, so Laurus Labs's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | +149.25% |
| 50-Day Moving Average | 2,053.59 |
| 200-Day Moving Average | 1,493.90 |
| Relative Strength Index (RSI) | 75.13 |
| Average Volume (20 Days) | 2,239,099 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Laurus Labs had revenue of INR 78.23 billion and earned 13.40 billion in profits. Earnings per share was 24.78.
| Revenue | 78.23B |
| Gross Profit | 47.22B |
| Operating Income | 18.89B |
| Pretax Income | 17.60B |
| Net Income | 13.40B |
| EBITDA | 23.83B |
| EBIT | 18.89B |
| Earnings Per Share (EPS) | 24.78 |
Balance Sheet
The company has 287.40 million in cash and 26.25 billion in debt, with a net cash position of -25.96 billion or -48.05 per share.
| Cash & Cash Equivalents | 287.40M |
| Total Debt | 26.25B |
| Net Cash | -25.96B |
| Net Cash Per Share | -48.05 |
| Equity (Book Value) | 61.81B |
| Book Value Per Share | 112.16 |
| Working Capital | 12.29B |
Cash Flow
In the last 12 months, operating cash flow was 13.35 billion and capital expenditures -14.45 billion, giving a free cash flow of -1.10 billion.
| Operating Cash Flow | 13.35B |
| Capital Expenditures | -14.45B |
| Depreciation & Amortization | 4.94B |
| Net Borrowing | 3.17B |
| Free Cash Flow | -1.10B |
| FCF Per Share | -2.03 |
Margins
Gross margin is 60.36%, with operating and profit margins of 24.14% and 17.13%.
| Gross Margin | 60.36% |
| Operating Margin | 24.14% |
| Pretax Margin | 22.49% |
| Profit Margin | 17.13% |
| EBITDA Margin | 30.46% |
| EBIT Margin | 24.14% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.40, which amounts to a dividend yield of 0.10%.
| Dividend Per Share | 2.40 |
| Dividend Yield | 0.10% |
| Dividend Growth (YoY) | 37.50% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 8.06% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.17% |
| Shareholder Yield | -0.07% |
| Earnings Yield | 1.02% |
| FCF Yield | -0.09% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for Laurus Labs is 2,156.29, which is -11.49% lower than the current price. The consensus rating is "Hold".
| Price Target | 2,156.29 |
| Price Target Difference | -11.49% |
| Analyst Consensus | Hold |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | 21.69% |
| EPS Growth Forecast (3Y) | 41.28% |
Stock Splits
The last stock split was on September 29, 2020. It was a forward split with a ratio of 5.
| Last Split Date | Sep 29, 2020 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |